The novel treatment of the medication represents a exciting advance in the management of the condition. Different to existing medications, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide399405.gynoblog.com/40714322/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment